Tower Research Capital (TRC)’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Buy |
23,227
+3,316
| +17% | +$2.43K | ﹤0.01% | 3764 |
|
|
2025
Q1 | $19.9K | Buy |
19,911
+18,593
| +1,411% | +$18.6K | ﹤0.01% | 2978 |
|
|
2024
Q4 | $14K | Sell |
1,318
-3,624
| -73% | -$38.4K | ﹤0.01% | 3489 |
|
|
2024
Q3 | $65.3K | Buy |
4,942
+1,256
| +34% | +$16.6K | ﹤0.01% | 2566 |
|
|
2024
Q2 | $36.2K | Buy |
3,686
+1,050
| +40% | +$10.3K | ﹤0.01% | 3348 |
|
|
2024
Q1 | $36.2K | Buy |
2,636
+78
| +3% | +$1.07K | ﹤0.01% | 2493 |
|
|
2023
Q4 | $43.6K | Buy |
+2,558
| New | +$43.6K | ﹤0.01% | 3220 |
|